56 related articles for article (PubMed ID: 7851045)
1. Lobar pilocytic astrocytomas of the cerebral hemispheres: II. Pathobiology--morphogenesis of the eosinophilic granular bodies.
Katsetos CD; Krishna L; Friedberg E; Reidy J; Karkavelas G; Savory J
Clin Neuropathol; 1994; 13(6):306-14. PubMed ID: 7851045
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical study on Rosenthal fibers in gliomas using anti-GFAP and anti-ubiquitin antibodies].
Kobayashi S; Mori H; Ikeuchi S; Takakura K
No To Shinkei; 1990 Jan; 42(1):59-64. PubMed ID: 1692468
[TBL] [Abstract][Full Text] [Related]
3. Distribution of lysosome-associated membrane proteins-1 and -2, and cathepsin D in eosinophilic granular bodies: possible relationship to cyst development in pilocytic astrocytomas.
Tung JN; Tsao TY; Tai CJ; Yeh KT; Cheng YW; Jiang MC
J Int Med Res; 2010; 38(4):1354-64. PubMed ID: 20926008
[TBL] [Abstract][Full Text] [Related]
4. Lobar pilocytic astrocytomas of the cerebral hemispheres: I. Diagnosis and nosology.
Katsetos CD; Krishna L
Clin Neuropathol; 1994; 13(6):295-305. PubMed ID: 7851044
[TBL] [Abstract][Full Text] [Related]
5. Immunocytochemical and ultrastructural studies of eosinophilic granular bodies in astrocytic tumors.
Murayama S; Bouldin TW; Suzuki K
Acta Neuropathol; 1992; 83(4):408-14. PubMed ID: 1575017
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas: comparative study with 11 pilocytic astrocytomas.
Amatya VJ; Akazawa R; Sumimoto Y; Takeshima Y; Inai K
Pathol Int; 2009 Feb; 59(2):80-5. PubMed ID: 19154260
[TBL] [Abstract][Full Text] [Related]
7. Neurotrophic regulation of mouse muscle beta-amyloid protein precursor and alpha 1-antichymotrypsin as revealed by axotomy.
Akaaboune M; Ma J; Festoff BW; Greenberg BD; Hantaï D
J Neurobiol; 1994 May; 25(5):503-14. PubMed ID: 8071658
[TBL] [Abstract][Full Text] [Related]
8. Production of amyloid beta protein precursor as a proteinase inhibitor by human astrocytic tumors.
Nakagawa T; Kabuto M; Kubota T; Kodera T; Sato K
Anticancer Res; 1999; 19(4B):2963-8. PubMed ID: 10652580
[TBL] [Abstract][Full Text] [Related]
9. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
10. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
[TBL] [Abstract][Full Text] [Related]
11. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
[TBL] [Abstract][Full Text] [Related]
12. Detection of apoptotic cells in archival tissue from diffuse astrocytomas using a monoclonal antibody to single-stranded DNA.
Korkolopoulou PA; Konstantinidou AE; Patsouris ES; Christodoulou PN; Thomas-Tsagli EA; Davaris PS
J Pathol; 2001 Mar; 193(3):377-82. PubMed ID: 11241419
[TBL] [Abstract][Full Text] [Related]
13. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
Nayak A; Ralte AM; Sharma MC; Singh VP; Mahapatra AK; Mehta VS; Sarkar C
Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
15. Assessment of protein conformation in human benign and malignant astrocytomas by reflectance Fourier transform infrared microspectroscopy.
Lee LS; Chi CW; Liu HC; Cheng CL; Li MJ; Lin SY
Oncol Res; 1998; 10(1):23-7. PubMed ID: 9613454
[TBL] [Abstract][Full Text] [Related]
16. Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation: grounds for designation as hamartomas.
Parsa CF; Givrad S
Br J Ophthalmol; 2008 Jan; 92(1):40-6. PubMed ID: 17962395
[TBL] [Abstract][Full Text] [Related]
17. Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature.
Tchoghandjian A; Fernandez C; Colin C; El Ayachi I; Voutsinos-Porche B; Fina F; Scavarda D; Piercecchi-Marti MD; Intagliata D; Ouafik L; Fraslon-Vanhulle C; Figarella-Branger D
Brain; 2009 Jun; 132(Pt 6):1523-35. PubMed ID: 19336457
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic inclusions of astrocytic elements of glial tumors: special reference to round granulated body and eosinophilic hyaline droplets.
Hitotsumatsu T; Iwaki T; Fukui M; Tateishi J
Acta Neuropathol; 1994; 88(6):501-10. PubMed ID: 7533470
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression.
Bodey B; Gröger AM; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(2A):1187-94. PubMed ID: 9137469
[TBL] [Abstract][Full Text] [Related]
20. Expression of survivin, an inhibitor of apoptosis protein, in tumors of the nervous system.
Sasaki T; Lopes MB; Hankins GR; Helm GA
Acta Neuropathol; 2002 Jul; 104(1):105-9. PubMed ID: 12070671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
